BECOME AN INVESTIGATOR
Getting involved in clinical trials as an investigator enables qualified healthcare professionals with opportunities to contribute to the development and advancement of medicines.
HEALTHCARE PROFESSIONALS
FIND CLINICAL TRIALS FOR YOUR PATIENTS
At Incyte, we support your efforts to connect patients to clinical trials, which will help bring innovative and investigational medicines to patients. We have a number of clinical trials planned or underway across a broad range of conditions.
LEARN ABOUT BECOMING A CLINICAL TRIAL INVESTIGATOR
Clinical data transparency is an important issue for Incyte—we are committed to making information about the clinical research we conduct visible and accessible. Click here for more information about our policies and our commitment to integrity and transparency.
JOIN AN INCYTE-SPONSORED TRIAL
Incyte currently has a number of clinical trials underway or planned across a variety of therapeutic areas.
To learn more about becoming an investigator in a United States Incyte-sponsored clinical trial, contact us at 1-855-4MED-INFO (855-463-3463) or [email protected]. For more information about becoming an investigator outside of the US in an Incyte-sponsored clinical trial, click here for contact information.
Investigators must meet certain criteria and selection is subject to the discretion of Incyte.
AREAS OF STUDY
With multiple drugs in clinical development, our rigorous pursuit of scientific excellence continues to be core to our company. Our researchers are focused on transforming the treatment of cancer and other diseases with expanded discovery efforts to identify biotherapeutics and a broad range of targets.
Incyte's drug discovery efforts were founded in 2002 by a team of world-class scientists striving to create innovative medicines for patients. The rigorous pursuit of scientific excellence remains at the core of our company today.
PIVOTAL SCIENCE
Our scientific innovation is based on a unique competency in medicinal chemistry, which is seamlessly integrated into a discovery process that is tailored to individual program needs. We have expanded our drug identification efforts to include biotherapeutics, which enables us to access a broad range of oncological drug targets. We continually modify the resourcing of our discovery efforts to maximize information content when and where we need it and ensure that each program, regardless of stage, is executed in the most efficient and data-rich manner possible.
Our discovery approach integrates target selection, portfolio "fit," compound quality, and pharmacodynamic optimization. This approach ensures we not only develop molecules with characteristics optimized for their intended use but also build a portfolio that is strategically coherent and synergy-rich.
TARGETED THERAPY
Open
Incyte's targeted therapy discovery strategy emphasizes the prosecution of therapeutic intervention points that lie in interdependent oncogenic pathways. This enables us to readily leverage cross-program knowledge throughout the research and development continuum as well as identify and exploit novel points of synergy.
IMMUNO-THERAPY
Open
Incyte's discovery strategy within the field of immunotherapy is based on the diversity of cells required to maintain an immune-suppressive microenvironment. Immune subversion by cancer cells is mediated by the action of multiple immune-regulatory cell types, and Incyte's discovery capabilities based on both small and large molecule modalities open distinct opportunities to target diverse mechanisms, including: IDO1, JAK, PI3Kδ, OX40, PD-1, and GITR.
NON-ONCOLOGY
Open
ADDITIONAL INFORMATION
INVESTIGATOR-INITIATED RESEARCH
Incyte supports significant independent research aimed at advancing the study of our products and compounds and/or related to disease areas of interest through its Investigator-initiated research (IIR) program. This program is open to physicians, researchers, and institutions interested in conducting external research.
If you have questions about investigator-initiated research or are interested in submitting a research proposal, please contact us at iir.incyte.com.
EXPANDED ACCESS PROGRAM
lncyte believes that conducting clinical trials to obtain the necessary approvals provides patients with the optimal mechanism for broad access to medicines. We recognize that some patients with serious or immediately life-threatening diseases may not be eligible for participation in a clinical trial, or may not have other options. Subject to appropriate internal review and approval based on the conditions in Incyte's Policy on Compassionate Use, Incyte in its sole discretion may choose to provide individual patients with access to an unapproved or investigational product outside of a clinical trial setting.
CLINICALTRIALS.GOV
The clinical trials listed on this website are Incyte-sponsored trials that are actively recruiting patients. To get additional information about Incyte-sponsored trials, such as study description, eligibility criteria, contact information, and facility names, please visit ClinicalTrials.gov.
REQUEST AN OFFICE VISIT WITH AN INCYTE MEDICAL SCIENCE LIAISON
If you are in the United States and have a question about a clinical trial or want to meet with a Medical Science Liaison, please click "OPEN" and fill out the form below to contact our Medical Information team.
INCYTE EDUCATIONAL GRANTS
Incyte supports the advancement of medical education as part of its commitment to address unmet needs. Through appropriate funding of educational grants to institutions, Incyte will support medically sound and compliant continuing education aimed at enhancing the knowledge of healthcare professionals and improving patient care.
To submit a grant request, please go to incytegrantsandgiving.com.
TRIAL TRANSPARENCY
Click here to read our Clinical Trial Transparency, Data Sharing, and Disclosure Practices.